This website is intended for healthcare professionals only

Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

Myelodysplastic Syndromes Foundation (MDSF)

Myelodysplastic Syndromes Foundation (MDSF)

The Myelodysplastic Syndromes Foundation was established by an international group of physicians and researchers to provide an ongoing exchange of information relating to MDS.

A major Foundation effort is our international information network. This network provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to physicians, nurses, pharmacists and patients.

In response to the needs expressed by patients, families, and healthcare professionals, we have established patient advocacy groups, research funding, and professional educational initiatives.

Momentum in MDS: Making Progress and Shaping a Better Future

December 5, 2025 | Orlando, FL

In the last decade, significant progress has been made in understanding the biology, genetics, and pathogenesis of myelodysplastic syndromes (MDS), while evolving topics such as the role of morphology and the need for more effective therapies have become increasingly relevant in 2025.

Momentum in MDS: Making Progress and Shaping a Better Future is an MDS Foundation continuing education program that will prompt and guide discussion intended to improve patient care, treatment, and outcomes in MDS.

Further Resources

Close Popup